Showing results (1581-1590 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|July 10, 2007
Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxelTomasz M Beer, Celestia S Higano, Mansoor Saleh, et al.
Investigational New Drugs|February 12, 2009
Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxicsNicolas Penel, Jean-Pierre Delord, Marie-Edith Bonneterre, et al.
Investigational New Drugs|February 12, 2009
N-4-iodophenyl-N'-2-chloroethylurea, a novel potential anticancer agent with colon-specific accumulation: radioiodination and comparative in vivo biodistribution profilesEmmanuelle Mounetou, Elisabeth Miot-Noirault, René C Gaudreault, et al.
Investigational New Drugs|January 14, 2009
B5, a novel pyrrole-substituted indolinone, exerts potent antitumor efficacy through G2/M cell cycle arrestXishan Xiong, Yingwei Zhang, Xiang Gao, et al.
Investigational New Drugs|April 9, 2009
Severe respiratory symptoms to oxaliplatin infusion: a case report of delayed hypersensitivity reactionSimona Potenza, Guglielmo Nasti, Alessandro Ottaiano, et al.
Investigational New Drugs|February 20, 2009
Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancerBryan J Schneider, Francis P Worden, Shirish M Gadgeel, et al.
Investigational New Drugs|March 31, 2009
Esophageal ulcer in a patient who received bevacizumabJudith Meza-Junco, Clarence Wong, Anthony Fields, et al.
Investigational New Drugs|November 4, 2022
Necitumumab plus gemcitabine and cisplatin in previously treated lung squamous cell carcinomaFumihiko Kinoshita, Yuka Oku, Shinkichi Takamori, et al.
Investigational New Drugs|November 4, 2022
Oral formulation of bendamustine hydrochloride for patients with advanced solid tumors; a phase 1 studyToshio Shimizu, Kazuhiko Nakagawa, Hidetoshi Hayashi, et al.
Investigational New Drugs|November 4, 2022
The influence of verapamil on the pharmacokinetics of the pan-HER tyrosine kinase inhibitor neratinib in rats: the role of P-glycoprotein-mediated effluxDefei Qi, Yuanyuan Dou, Wenke Zhang, et al.
Pageof 372